MedPath

ATROPINE SULFATE

ATROPINE SULFATE INJECTION, USP 1mg/mL 1mL VIAL

Approved
Approval ID

c4c658a0-93f0-6639-e053-2a95a90abffa

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jun 14, 2021

Manufacturers
FDA

HF Acquisition Co LLC, DBA HealthFirst

DUNS: 045657305

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

ATROPINE SULFATE

PRODUCT DETAILS

NDC Product Code51662-1509
Application NumberN/A
Marketing CategoryN/A
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Effective DateJune 14, 2021
Generic NameATROPINE SULFATE

INGREDIENTS (4)

WATERInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM CHLORIDEInactive
Quantity: 9 mg in 1 mL
Code: 451W47IQ8X
Classification: IACT
ATROPINE SULFATEActive
Quantity: 1 mg in 1 mL
Code: 03J5ZE7KA5
Classification: ACTIB
SULFURIC ACIDInactive
Code: O40UQP6WCF
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ATROPINE SULFATE - FDA Drug Approval Details